SCHEMBL312402

SCHEMBL312402

CCOC(=O)Nc1cc(O)cnc1-c1cc(=O)c2cccc(O)c2o1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.43
KDM4E B2RXH2 3/20 0.43
HSD17B10 Q99714 2/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 3/20 0.41
MAOB P27338 2/20 0.39
CYSLTR2 Q9NS75 6/20 0.38
CYSLTR1 Q9Y271 6/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
MAOA P21397 1/20 0.38
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
GPR35 Q9HC97 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312875 0.86 KDM4E (0.58) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311513 0.85 AR (0.45) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311431 0.83 HPGD (0.46) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311723 0.83 HPGD (0.43) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311598 0.82 CSNK2A2 (0.46) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311971 0.82 AKR1B1 (0.51) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311535 0.76 HPGD (0.44) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311741 0.74 KDM4E (0.40) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311138 0.73 HPGD (0.58) HPGDKDM4EHSD17B10LMNAALDH1A1
SCHEMBL311904 0.73 HPGD (0.40) HPGDKDM4EHSD17B10LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838296-B1 FLAVANOIDS AND ISOFLAVANOIDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES RESVERLOGIX CORP (CA) 2012-08-08 EP disclosed
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed